Potential therapeutical effects of cannabidiol in children with pharmacoresistant epilepsy

Medical Hypotheses

Volumn 68, Issue 4, 2007, Pages 920-921

  Cortesi, Mariachiara ^a   Fusar Poli, Paolo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIDIOL; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABIS;

ANXIETY DISORDER; BIPOLAR DISORDER; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EPILEPSY; HUMAN; HYPOXIA; LETTER; MENTAL DISEASE; MONOTHERAPY; NERVE EXCITABILITY; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; AEROSOLS; ANTICONVULSANTS; BIPOLAR DISORDER; CANNABIDIOL; CHILD; DRUG RESISTANCE; EPILEPSY; HUMANS; MODELS, BIOLOGICAL;

EID: 33846529870     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.09.030     Document Type: Letter

References (6)

1. Zuardi A., Crippa J., Hallak J., Moreira F., and Guimarae4s F. Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia. Braz J Med Biol Res 39 (2006) 421-429
2. Karler R., and Turkanis S.A. The cannabinoids as potential antiepileptics. J Clin Pharmacol 21 8-9 Suppl. (1981) 437S-448S
3. Lutz B. On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochem Pharmacol 68 (2004) 1691-1698
4. Mechoulam R., and Lichtman A. Stout guards of the central nervous system. Science 302 (2003) 65-66
5. Ashton A., Moore A., Gallagher P., and Young A. Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. J Psychopharmacol 19 3 (2005) 293-300
6. Lorenz R. On the application of cannabis in paediatrics and epileptology. Neuroendocrinol Lett 25 1-2 (2004) 40-44